Results 81 to 90 of about 325 (159)
Impact of cancer on outcomes following breakthrough ischaemic stroke on oral anticoagulants for atrial fibrillation: insights from the ASPERA-R study. [PDF]
Eur Stroke JFoschi M, De Santis F, Gabriele F, D'Anna L, Zini A, Paolucci M, Forlivesi S, Migliaccio L, Viola MM, Rizzo AC, Sessa M, Schwarz G, Tortorella R, Banerjee S, Desai G, Jaffar M, Prandin G, Pantoni L, Mele F, Scopelliti G, Cova I, Valente M, Maisano D, Antonelli L, Bagnato MR, Di Mauro G, Bernocchi F, Di Donna MG, Casolla B, Mazloum MP, Kacani K, Djeghlal NA, González-Martín L, Rigual R, Fuentes B, Hervás C, Candelaresi P, Andreone V, De Mase A, Spina E, de Sousa DA, Souza MA, Fior A, Serôdio M, Caliandro P, Zauli A, Reale G, Abdelalim A, Ahmed S, Soliman NM, Zhang L, Latimer T, Elboghday M, Elbassiouny AA, Roushdy T, Shokri H, Ferrari F, Loizzo ND, Mazzacane F, Guarino M, Barone V, Forti P, Rinaldi G, Rossi MV, Laterza V, Frisullo G, Rizzo PA, Broccolini A, Mannino M, Terruso V, Caggiula M, Rizzo A, Fonseca AC, Fonseca AC, Antunes B, Barbosa AM, Budincevic H, Crnac P, Viticchi G, Silvestrini M, Barba L, Otto M, Otto M, Lochner P, Lochner P, Landau B, Buddha S, Khalil R, Piscaglia MG, Minguzzi E, Zedde M, Nasreldein A, Vinciguerra L, Costa L, Elsayed AE, AlBanna M, Tudisco L, Mosconi MG, Merlino G, Polymeris A, Ornello R, Sacco S. +101 moreeuropepmc +1 more sourceSex Differences in Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants for Atrial Fibrillation: An ASPERA-R Inverse Probability Weighted Analysis. [PDF]
J Am Heart AssocFoschi M, D'Anna L, Gabriele F, Ornello R, Zini A, Paolucci M, Forlivesi S, Migliaccio L, Viola MM, Cascio Rizzo A, Sessa M, Schwarz G, Tortorella R, Banerjee S, Desai G, Jaffar M, Prandin G, Pantoni L, Mele F, Scopelliti G, Cova I, Valente M, Maisano D, Antonelli L, Bagnato MR, Di Mauro G, Bernocchi F, Di Donna MG, Casolla B, Mazloum P, Bruno C, Alvarez B, González-Martín L, Rigual R, Fuentes B, Hervás C, Candelaresi P, Andreone V, De Mase A, Spina E, de Sousa DA, Souza MA, Fior A, Serôdio M, Caliandro P, Zauli A, Reale G, Abdelalim A, Ahmed S, Soliman NM, Zhang L, Latimer T, Elboghday M, Elbassiouny AA, Roushdy T, Shokri H, Ferrari F, Loizzo ND, Mazzacane F, Guarino M, Barone V, Forti P, Rinaldi G, Rossi MV, Laterza V, Frisullo G, Rizzo PA, Broccolini A, Mannino M, Terruso V, Caggiula M, Lucchese G, Fonseca AC, Antunes B, Barbosa AM, Budincevic H, Crnac P, Viticchi G, Silvestrini M, Barba L, Musienko V, Otto M, Lochner P, Landau B, Buddha S, Khalil R, Piscaglia MG, Minguzzi E, Zedde M, Nasreldein A, Vinciguerra L, Costa L, Elsayed AE, AlBanna M, Tudisco L, Mosconi MG, Merlino G, Polymeris A, De Santis F, Sacco S. +99 moreeuropepmc +1 more sourceAdjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03). [PDF]
J Clin Oncol, 2022 Gnant M, Dueck AC, Frantal S, Martin M, Burstein HJ, Greil R, Fox P, Wolff AC, Chan A, Winer EP, Pfeiler G, Miller KD, Colleoni M, Suga JM, Rubovsky G, Bliss JM, Mayer IA, Singer CF, Nowecki Z, Hahn O, Thomson J, Wolmark N, Amillano K, Rugo HS, Steger GG, Hernando Fernández de Aránguiz B, Haddad TC, Perelló A, Bellet M, Fohler H, Metzger Filho O, Jallitsch-Halper A, Solomon K, Schurmans C, Theall KP, Lu DR, Tenner K, Fesl C, DeMichele A, Mayer EL, PALLAS groups and investigators. +40 moreeuropepmc +1 more source
